The era of RNA interference medicines: the clinical landscape of synthetic gene silencing drugs
ABSTRACT - Therapeutic oligonucleotides, such as small interfering RNAs (siRNAs), provide a simple and effective tool to modulate the expression of any gene. siRNAs harness the RNA interference (RNAi) pathway to degrade disease-associated messenger RNAs (mRNAs). The inherent sequence specificity and...
Autor principal: | |
---|---|
Outros Autores: | |
Formato: | article |
Idioma: | eng |
Publicado em: |
2020
|
Assuntos: | |
Texto completo: | http://hdl.handle.net/10400.21/11331 |
País: | Portugal |
Oai: | oai:repositorio.ipl.pt:10400.21/11331 |